Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Minoxidil

This article was originally published in The Tan Sheet

Executive Summary

Foam delivery system for OTC hair loss treatment ingredient under development, Palo Alto, Calif.-based Connetics says in teleconference March 21. Firm may commercialize product itself or seek marketing partners; Rogaine marketer Pharmacia says it currently has no interest in alternative delivery forms. Connetics also developing foam delivery for ketoconazole 2% and plans to file an NDA during first half of 2002 upon completing clinical trial this year; the 2% dose (McNeil's Rx Nizoral) recently was associated with hair loss benefits, prompting McNeil to investigate a new indication (1"The Tan Sheet" March 12, p. 3). Connetics acquired Victoria, Australia-based Soltec Research for $16.9 mil. in cash March 20. Soltec developed a mousse delivery form for Bayer's Rid pediculicide approved March 2000
Advertisement

Related Content

Ketoconazole Positive Effects On Hair Loss Suggested By Study Data
Ketoconazole Positive Effects On Hair Loss Suggested By Study Data

Topics

Advertisement
UsernamePublicRestriction

Register

PS092343

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel